JP Morgan Reiterates Underweight Rating on QuidelOrtho Corporation (QDEL)

Market Context

QuidelOrtho Corporation operates in the Healthcare sector. The stock currently trades at $18.18 with a market capitalization of $2.0B. The stock has declined 39.3% over the past 52 weeks.

Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for QuidelOrtho Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for QuidelOrtho Corporation

Among the 10 most recent ratings: 0 Buy, 8 Hold, 2 Sell.

Date	Firm	Rating	Price Target
Jul 01, 2026	JP Morgan	Underweight	N/A
May 07, 2026	Jefferies	Hold	N/A
May 06, 2026	Citigroup	Neutral	N/A
Apr 10, 2026	UBS	Neutral	N/A
Feb 12, 2026	Citigroup	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View QDEL Stock Page